Immunocore Holdings (IMCR) Earnings Analysis
Immunocore Holdings (IMCR) next reports earnings on 2026-08-06, consensus EPS -0.01 USD. Last quarter (2026-02-25) it missed with EPS -0.6 USD vs -0.28 USD est (-114.3%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -94.93.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IMCR next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.01 USD |
| Revenue estimate | 0.15B |
IMCR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -0.6 USD | -0.28 USD | -114.3% | Miss |
| 2025-11-06 | 0.01557 USD | -0.3 USD | +105.2% | Beat |
| 2025-02-26 | -0.47 USD | -0.31 USD | -51.6% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
IMCR valuation and analyst view
| Trailing P/E | -94.93 |
|---|---|
| Trailing EPS | -0.37082 USD |
| Price / book | 4.58 |
| Dividend yield | 0.00% |
| Market cap | 1.74B |
| Analyst consensus | Buy (9 buy / 5 hold / 0 sell) |
| Avg price target | 47.25 USD |
Related research pages
Frequently asked questions
When is Immunocore Holdings (IMCR)'s next earnings date?
Immunocore Holdings is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.01 USD and revenue estimate of 0.15B.
Did IMCR beat earnings last quarter?
In its 2026-02-25 report, IMCR posted EPS of -0.6 USD versus a -0.28 USD estimate — a miss of 114.3%.
What is IMCR's earnings track record?
Over the last 3 reported quarters with consensus data, IMCR beat estimates 1 times (33%).
What is IMCR's current P/E ratio and EPS?
IMCR trades at a trailing P/E of -94.93 on trailing EPS of -0.37082425150916376 USD.
What do analysts rate IMCR?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 9 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 47.25 USD.